Ahmad, E., Lim, S., Lamptey, R., Webb, D. R. & Davies, M. J. Type 2 diabetes. Lancet 400, 1803–1820 (2022).
Google Scholar
Li, J. et al. The mediterranean diet, plasma metabolome, and cardiovascular disease risk. Eur. Heart J. 41, 2645–2656 (2020).
Google Scholar
Morze, J. et al. Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies. Diabetes Care. 45, 1013–1024 (2022).
Google Scholar
Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N. Engl. J. Med. 346, 393–403 (2002).
Google Scholar
Tuomilehto, J. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343–1350 (2001).
Google Scholar
Wishart, D. S. et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 50, D622–D631 (2022).
Google Scholar
Pallares-Méndez, R., Aguilar-Salinas, CA & Cruz-Bautista, I. Del Bosque-Plata, L. Metabolomics in diabetes, a review. Ann. Med. 48, 89–102 (2016).
Google Scholar
Guasch-Ferré, M. et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 39, 833–846 (2016).
Google Scholar
de Mello, V. D. et al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish diabetes prevention study. Sci. Rep. 7, 1–12 (2017).
Google Scholar
Kivelä, J., Meinilä, J., Uusitupa, M., Tuomilehto, J. & Lindström, J. Longitudinal Branched-Chain amino Acids, lifestyle Intervention, and type 2 diabetes in the Finnish diabetes prevention study. J. Clin. Endocrinol. Metabolism. 107, 2844–2853 (2022).
Google Scholar
del Sevilla-Gonzalez, R. M. et al. Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes. BMJ Open. Diabetes Res. & Care 10 (2022).
Walford, G. A. et al. Metabolite profiles of diabetes incidence and intervention response in the diabetes prevention program. Diabetes 65, 1424–1433 (2016).
Google Scholar
Pihlajamäki, J. et al. Digitally supported program for type 2 diabetes risk identification and risk reduction in real-world setting: protocol for the StopDia model and randomized controlled trial. BMC public. Health. 19, 1–13 (2019).
Google Scholar
Lakka, T. A. et al. Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk–A stop diabetes pragmatic randomised trial. The Lancet Reg. Health–Europe 24 (2023).
Makrilakis, K. et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 37, 144–151 (2011).
Google Scholar
Association, A. D. Diagnosis and classification of diabetes mellitus. Diabetes Care. 33, S62–S69 (2010).
Google Scholar
Jalkanen, K. et al. Comparison of communication channels for large-scale type 2 diabetes risk screening and intervention recruitment: empirical study. JMIR Diabetes. 6, e21356 (2021).
Google Scholar
Lindström, J. et al. Formation and validation of the healthy diet index (HDI) for evaluation of diet quality in healthcare. Int. J. Environ. Res. Public Health. 18, 2362 (2021).
Google Scholar
Klåvus, A. et al. Notame: workflow for Non-Targeted LC–MS metabolic profiling. Metabolites 10, 135 (2020).
Google Scholar
Lapatto, H. A. et al. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. Sci. Adv. 9, eadd5163 (2023).
Google Scholar
Tsugawa, H. et al. MS-DIAL: data-independent MS/MS Deconvolution for comprehensive metabolome analysis. Nat. Methods. 12, 523–526 (2015).
Google Scholar
Tsugawa, H. et al. Hydrogen rearrangement rules: computational MS/MS fragmentation and structure Elucidation using MS-FINDER software. Anal. Chem. 88, 7946–7958 (2016).
Google Scholar
Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis. Metabolomics 3, 211–221 (2007).
Google Scholar
Vangipurapu, J., Fernandes Silva, L., Kuulasmaa, T., Smith, U. & Laakso, M. Microbiota-related metabolites and the risk of type 2 diabetes. Diabetes Care. 43, 1319–1325 (2020).
Google Scholar
Feldman, E. L., Russell, J. W., Sullivan, K. A. & Golovoy, D. New insights into the pathogenesis of diabetic neuropathy. Curr. Opin. Neurol. 12, 553–563 (1999).
Google Scholar
Baumgartner, C. et al. Potential role of skeletal muscle Glycerophosphocholine in response to altered fluid balance in humans: an in vivo nuclear magnetic resonance study. Am. J. Physiology-Endocrinology Metabolism. 324, E339–E346 (2023).
Google Scholar
Prada, M. et al. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohort. Clin. Nutr. 40, 4988–4999 (2021).
Google Scholar
Pfeuffer, M. & Jaudszus, A. Pentadecanoic and heptadecanoic acids: multifaceted odd-chain fatty acids. Adv. Nutr. 7, 730–734 (2016).
Google Scholar
Farrell, E. K. & Merkler, D. J. Biosynthesis, degradation and Pharmacological importance of the fatty acid amides. Drug Discovery Today. 13, 558–568 (2008).
Google Scholar
Lambert, D. M. & Di Marzo, V. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr. Med. Chem. 6, 757–773 (1999).
Google Scholar
Gruden, G., Barutta, F., Kunos, G. & Pacher, P. Role of the endocannabinoid system in diabetes and diabetic complications. Br. J. Pharmacol. 173, 1116–1127 (2016).
Google Scholar
Dohnalová, L. et al. A microbiome-dependent gut–brain pathway regulates motivation for exercise. Nature, 1–9 (2022).
Huynh, K. et al. High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors. Cell. Chem. Biology. 26, 71–84 (2019).
Google Scholar
Orsavova, J., Misurcova, L., Ambrozova, V., Vicha, J., Mlcek, J. & R. & Fatty acids composition of vegetable oils and its contribution to dietary energy intake and dependence of cardiovascular mortality on dietary intake of fatty acids. Int. J. Mol. Sci. 16, 12871–12890 (2015).
Google Scholar
Xia, T. et al. A longitudinal study on associations of moderate-to-vigorous physical activity with plasma monounsaturated fatty acids in pregnancy. Front. Nutr. 9, 983418 (2022).
Google Scholar
Zhu, X. et al. Association between fatty acids and the risk of impaired glucose tolerance and type 2 diabetes mellitus in American adults: NHANES 2005 – 2016. Nutr. Diabetes. 13, 8 (2023).
Google Scholar
Dudzik, D. et al. Metabolic fingerprint of gestational diabetes mellitus. J. Proteom. 103, 57–71 (2014).
Google Scholar
Haikonen, R., Kärkkäinen, O., Koistinen, V. & Hanhineva, K. Diet-and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease. Trends Endocrinol. & Metabolism (2022).
Kärkkäinen, O. et al. Whole grain intake associated molecule 5-aminovaleric acid betaine decreases β-oxidation of fatty acids in mouse cardiomyocytes. Sci. Rep. 8, 13036 (2018).
Google Scholar
O’Sullivan, J. F. et al. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J. Clin. Investig. 127, 4394–4402 (2017).
Google Scholar
Ottosson, F. et al. Dimethylguanidino valerate: a lifestyle-related metabolite associated with future coronary artery disease and cardiovascular mortality. J. Am. Heart Association. 8, e012846 (2019).
Google Scholar
Chen, Y. et al. Associations between serum amino acids and incident type 2 diabetes in Chinese rural adults. Nutr. Metabolism Cardiovasc. Dis. 31, 2416–2425 (2021).
Google Scholar
Thomson, S. C. et al. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J. Clin. Investig. 107, 217–224 (2001).
Google Scholar
Lankinen, M. A. et al. Plasma fatty acids as predictors of glycaemia and type 2 diabetes. Diabetologia 58, 2533–2544 (2015).
Google Scholar
Adams, S. H. et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid β-oxidation and altered Tricarboxylic acid cycle activity in type 2 diabetic African-American women. J. Nutr. 139, 1073–1081 (2009).
Google Scholar
Veronese, N. et al. Serum dehydroepiandrosterone sulfate and risk for type 2 diabetes in older men and women: the Pro. VA study. Can. J. Diabetes. 40, 158–163 (2016).
Google Scholar
Ennour-Idrissi, K., Maunsell, E. & Diorio, C. Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Res. 17, 1–11 (2015).
Google Scholar
Sánchez-Guijo, A. et al. Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: evidence from steroid sulfatase deficiency. Mol. Cell. Endocrinol. 437, 142–153 (2016).
Google Scholar
Buergel, T. et al. Metabolomic profiles predict individual multidisease outcomes. Nat. Med. 28, 2309–2320 (2022).
Google Scholar
